Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

NCT00132314 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00132314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Lead sponsor
US Department of Veterans Affairs
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2009
Enrollment
382 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia